Life Sciences PreciseDx Appoints Life Science Experts, Molly Harper and Eric Converse, to Board of Directors AIT News Desk Mar 17, 2022 PreciseDx, the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology features,…
Healthcare Management PreciseDx Raises $10.75 Million Series A Preferred from Healthcare Industry Leaders To Commercialize… AIT News Desk Jan 12, 2022 Services Improve the Information Available to Oncologists and Pathologists in Determining Patient Risk Profiles and Treatment Diagnostic Industry…